| Literature DB >> 32265741 |
Robert Csapo1, Matthias Gumpenberger1, Barbara Wessner2.
Abstract
Skeletal muscle represents the largest body-composition component in humans. In addition to its primary function in the maintenance of upright posture and the production of movement, it also plays important roles in many other physiological processes, including thermogenesis, metabolism and the secretion of peptides for communication with other tissues. Research attempting to unveil these processes has traditionally focused on muscle fibers, i.e., the contractile muscle cells. However, it is a frequently overlooked fact that muscle fibers reside in a three-dimensional scaffolding that consists of various collagens, glycoproteins, proteoglycans, and elastin, and is commonly referred to as extracellular matrix (ECM). While initially believed to be relatively inert, current research reveals the involvement of ECM cells in numerous important physiological processes. In interaction with other cells, such as fibroblasts or cells of the immune system, the ECM regulates muscle development, growth and repair and is essential for effective muscle contraction and force transmission. Since muscle ECM is highly malleable, its texture and, consequently, physiological roles may be affected by physical training and disuse, aging or various diseases, such as diabetes. With the aim to stimulate increased efforts to study this still poorly understood tissue, this narrative review summarizes the current body of knowledge on (i) the composition and structure of the ECM, (ii) molecular pathways involved in ECM remodeling, (iii) the physiological roles of muscle ECM, (iv) dysregulations of ECM with aging and disease as well as (v) the adaptations of muscle ECM to training and disuse.Entities:
Keywords: aging; connective tissue; diabetes; exercise training; fibrosis; gene expression; matrix metallopeptidase; muscle remodeling
Year: 2020 PMID: 32265741 PMCID: PMC7096581 DOI: 10.3389/fphys.2020.00253
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
FIGURE 1Main components of the skeletal muscle extracellular matrix and its linkage to the contractile components of muscle.
Overview of collagenous components of the skeletal muscle extracellular matrix.
| Gene(s) | Skeletal muscle RNA expression (protein expression myocytes)* | Protein | Form | Appearance | Role | Source |
| COL1A1-2 | 1: 11.0 NX (not detected) 2: 12.1 NX (low) | Collagen type I alpha 1 and 2 chains | Fibrils | Endo-, peri-, and epimysium | Forms strong parallel fibers, confers tensile strength and rigidity | |
| COL3A1 | 14.5 NX (not detected) | Collagen type III alpha 1 chain | Fibrils | Endo- and perimysium, myotendinous junction | Forms a loose meshwork of fibers, confers compliance | |
| COL4A1-6 | 1: 24.6 NX (not detected) 2: 26.3 NX (high) 3: 17.8 NX (not detected) 4: 7.5 NX (no data) 5: 4.8 NX (no data) 6: 1.0 NX (no data) | Collagen type IV alpha 1-6 chains | Helices | Basal lamina | Produces a network structure, constitutes the basis of the basal lamina | |
| COL5A1-3 | 1: 5.0 NX (not detected) 2: 3.7 NX (no data) 3: 15.4 NX (medium) | Collagen type V alpha 1-3 chains | Fibrils | Endomysium | Control of collagen fibrillogenesis | |
| COL6A1-6 | 1: 20.0 NX (not detected) 2: 30.6 NX (not detected) 3: 31.8 NX (not detected) 4: no data 5: 0.2 NX (low) 6: 0.0 NX (medium) | Collagen type VI alpha 1-6 chains | Beaded filaments | Endo-, peri-, and epimysium (α6-chain) Basal lamina (α3-chain) Myotendinous junction (α5-chain) | Interacts with a large number of molecules and cell surface receptors, maintains muscle functional integrity. Mutations associated with fibrosis and Ullrich, Bethlem or Myosclerosis myopathies | |
| COL12A1 | 21.6 NX (medium) | Collagen type XII alpha 1 chain | FACIT | Endo- and perimysium, myotendinous junction | Linkage protein between fibrillar collagens and other ECM components | |
| COL13A1 | 2.7 NX (not detected) | Collagen type XIII alpha 1 chain | MACIT | Neuromuscular junction | Regulation and formation of neuromuscular synapse. Lack associated with myasthenia | |
| COL14A1 | 7.6 NX (not detected) | Collagen type XIV alpha 1 chain | FACIT | Endo- and perimysium, myotendinous junction | Linkage protein between fibrillar collagens and other ECM components. Increases following training at myotendinous junction (protection against strain injury?) | |
| COL15A1 | 12.8 NX (low to medium) | Collagen type XV alpha 1 chain | Multiplexin | Basement membrane | Stabilizes muscle cells and microvessels. Guides motor axons toward muscle targets. Deficiency increases vulnerability to exercise-induced muscle injury and leads to mild forms of myopathies | |
| COL18A1 | 8.1 NX (not detected) | Collagen type XVIII alpha 1 chain | Multiplexin | Basement membrane | May bind growth factors. May link the basement membrane to other basement membrane glycoproteins and endomysium | |
| COL19A1 | 3.7 NX (low) | Collagen type XIX alpha 1 chain | FACIT | Basement membrane | Presence at early embryonic stages is relevant for the muscle tissue differentiation. Acts as a cross-bridge between fibrils and other extracellular matrix molecules | |
| COL22A1 | 0.5 NX (not detected) | Collagen type XXII alpha 1 chain | FACIT | Myotendinous junction | Integrates ECM and contributes to mechanical stability of the myotendinous junction. Knockdown of COL22A1 results in dystrophy-like muscle phenotype in zebrafish |